Explore
Validate
LearnADI-SPA-523-D
antibody from Enzo Life Sciences
Targeting: HSPB1
CMT2F, Hs.76067, Hsp25, HSP27, HSP28
Western blot
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ADI-SPA-523-D - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ADI-SPA-523-D, RRID:AB_2039222
- Product name
- [pSer78]HSP27 polyclonal antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Protein A affinity purified.
- Reactivity
- Human, Rat, Bovine, Guinea Pig, Simian
- Host
- Rabbit
- Vial size
- 50 μg
- Storage
- -20°C
- Handling
- Avoid freeze/thaw cycles.
Submitted references Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients.
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Tokuda H, Kuroyanagi G, Tsujimoto M, Enomoto Y, Matsushima-Nishiwaki R, Onuma T, Kojima A, Doi T, Tanabe K, Akamatsu S, Iida H, Ogura S, Otsuka T, Iwama T, Tanikawa T, Ishikawa K, Kojima K, Kozawa O
PloS one 2015;10(6):e0128977
PloS one 2015;10(6):e0128977
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D, Canudas AM, Pallàs M, Camins A, Camarasa J, Escubedo E
Naunyn-Schmiedeberg's archives of pharmacology 2003 May;367(5):490-9
Naunyn-Schmiedeberg's archives of pharmacology 2003 May;367(5):490-9
No comments: Submit comment
Supportive validation
- Submitted by
- Enzo Life Sciences (provider)
- Main image
- Experimental details
- Western blot analysis of HSP27 (pSer78), pAb: Lane 1 MW marker, Lane 2 phospho HSP27 (Prod. No. ADI-SPP-716), Lane 3 non-phospho HSP27 (Prod. No. ADI-SPP-715) and Lane 4 MDBK (weak reactivity).
